PlainRecalls
FDA Drug Low Class III Terminated

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10

Reported: September 20, 2017 Initiated: May 5, 2017 #D-1134-2017

Product Description

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10

Reason for Recall

PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Details

Recalling Firm
Ascend Laboratories LLC
Units Affected
1212 bottles
Distribution
Nationwide in the USA.
Location
Montvale, NJ

Frequently Asked Questions

What product was recalled?
AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10. Recalled by Ascend Laboratories LLC. Units affected: 1212 bottles.
Why was this product recalled?
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 20, 2017. Severity: Low. Recall number: D-1134-2017.